Jane Street’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
Other funds holding SLS
Jane Street's SLS Position: Q3 2026 in Review
Jane Street reduced its SELLAS Life Sciences (SLS) stake by 86% in Q3 2026, selling an estimated $5.5M and leaving 69,607 shares worth $857K. The position accounts for ﹤0.01% of the portfolio, ranked #6797.
Jane Street first reported a position in SLS in Q3 2019 and has held it in 12 quarters since. The position peaked at $7.5M in Q2 2026. 218 funds tracked by Wall St. Rank hold SLS as of Q3 2026.
- Jane Street held 69,607 shares of SELLAS Life Sciences worth $857K as of Q3 2026.
- Jane Street sold 438,822 SELLAS Life Sciences shares in Q3 2026, an estimated $5.5M.
- SELLAS Life Sciences made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #6797 holding.
- Jane Street first reported a position in SELLAS Life Sciences in Q3 2019 and has held it in 12 quarters since.
- Jane Street's SELLAS Life Sciences position peaked at $7.5M in Q2 2026.
- 218 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.